{"id":199516,"name":"MASSACHUSETTS BIOTECHNOLOGY COUNCIL","slug":"massachusetts-biotechnology-council","state":"MA","country":"United States of America","description":"Trade association dedicated to advancing research","totalSpending":247500,"filings":32,"yearlySpending":[{"year":2018,"income":20000},{"year":2019,"income":20000},{"year":2020,"income":20000},{"year":2021,"income":20000},{"year":2022,"income":20000},{"year":2023,"income":27500},{"year":2024,"income":60000},{"year":2025,"income":60000}],"issues":[{"code":"CPT","display":"Copyright/Patent/Trademark"},{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"ACC","display":"Accounting"},{"code":"PHA","display":"Pharmacy"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"}],"firms":["PARK STREET STRATEGIES, LLC"],"lobbyists":["JOHN HEFFERNAN"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","HOUSE OF REPRESENTATIVES","Natl Institutes of Health (NIH)","Patent & Trademark Office (PTO)","SENATE"],"sampleDescriptions":["Support legislation to strengthen U.S. Patent System","Meetings regarding issues associated with the Patient Protection and Affordable Care Act's and alternative legislation's impact on the biotechnology industry, including issues related to biosimilars, ","Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.","Support legislation to fund the National Institutes of Health for Fiscal Year 2019","Monitor health and tax legislation ptertaining to bioltechnology industry."]}